Cargando…
Emerging immunotherapies for autoimmune kidney disease
Autoimmunity is a leading cause of chronic kidney disease and loss of native and transplanted kidneys. Conventional immunosuppressive therapies can be effective but are non-specific, noncurative, and risk serious side effects such as life-threatening infection and cancer. Novel therapies and targete...
Autores principales: | Foster, Mary Helen, Ord, Jeffrey Robinson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605834/ https://www.ncbi.nlm.nih.gov/pubmed/30550361 http://dx.doi.org/10.1080/21645515.2018.1555569 |
Ejemplares similares
-
Targeted Immunotherapy for Autoimmune Disease
por: Jung, Seung Min, et al.
Publicado: (2022) -
Novel emerging biomarkers to immunotherapy in kidney cancer
por: Ged, Yasser, et al.
Publicado: (2021) -
Immunotherapy in patients with autoimmune disease
por: Rakshit, Sagar, et al.
Publicado: (2020) -
Immunotherapy of Autoimmune Diseases with Nonantibiotic Properties of Tetracyclines
por: Park, Chan-Su, et al.
Publicado: (2020) -
Immunotherapy to treat malignancy in patients with pre-existing autoimmunity
por: Boland, Patrick, et al.
Publicado: (2020)